ClinicalTrials.gg
Status unknownNCT03387800Updated Jan 2, 2018

RCT for Evaluation of Online Social Networking Intervention in Smoking Cessations

An interventional study of Basic health education messages and WeChat interactive peer support group in Self Efficacy and Health Behavior, sponsored by Chinese University of Hong Kong. Status unknown at 1 site in Hong Kong. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-01-02.

Primary conditionSmoking CessationRegistry: Health BehaviorReclassifiedWhy we changed it
Registry
Health Behavior — the first condition term the registry derived for this study.
ClinicalTrials.gg
Smoking Cessation
Why
  1. The study's title name Smoking Cessation, a narrower term within Health Behavior.
Confidence
High: the new condition is named in the study's own title. Of 46 hand-checked studies reclassified this way, 72% were exactly right and 89% in the right disease family; the registry's first term was right for 4% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Dec 2017), so the status shown — last known as Active, not recruiting — may be out of date.

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Aug 2015, registered Dec 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
408
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 59 studies in Smoking Cessation with a site in Hong Kong — 10 open to participants now, 14 under way, none of them phase 3. Smoking Cessation · Hong Kong.

Planned enrollment
22nd of 55
408 · median 200
Started
2015
with 1 other
No phase
55 of 59
10 open now
Registered
13th of 59
by date
Lead sponsor
3 of 59
Chinese University of Hong Kong

Among the 59 studies in Smoking Cessation with a site in Hong Kong, this one is the 22nd largest by planned enrollment of the 55 interventional ones that give a count, is one of 2 that started in 2015, is one of 55 with no phase, and was the 13th registered.

Smoking Cessation

1,582 studies on the registry are indexed under Smoking Cessation; 198 are open to participants now.

Browse Smoking Cessation studies →

Open to participants now

10 of the 59 studies in Smoking Cessation with a site in Hong Kong are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Hong Kong have not opened yet or have stopped. Only those recruiting at a site in Hong Kong →

Who these studies take

Of the 137 Smoking Cessation studies recruiting now, 93 (68%) set no upper age limit and 37 (27%) stop at 75 or younger; 6 take children under 18; 41 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 59 studies in Smoking Cessation with a site in Hong Kong, or all of them as a file.
02

Study summary

The proposed RCT evaluates the efficacy of the aforementioned novel 2-month online smoking cessation intervention in increasing 7-day point prevalence quit rate over a 6-month follow-up period among Chinese adult smokers in Hong Kong.

Read the detailed description

Aims and hypothesis: The proposed RCT evaluates the efficacy of the aforementioned novel 2-month online smoking cessation intervention in increasing 7-day point prevalence quit rate over a 6-month follow-up period among Chinese adult smokers in Hong Kong. It is hypothesized that the quit rate of the intervention group would be higher than that of the control group at 6 month follow up (i.e. one-sided hypothesis).

Design and subjects: The RCT study will randomize participants into the intervention group or the control group. Prior to randomization, a baseline telephone survey will be conducted. Phone interviews will be conducted to evaluate the outcomes at Months 3 and 6 after completion of the intervention. Interviewers will be blinded from the randomization status. The inclusion criteria are: i) current smokers who have smoked at least one cigarette in the past seven days prior to the baseline survey, ii) age 18 years old or above, iii) able to communicate in Chinese (Cantonese), iv) having access to a smart phone or mobile electronic devices and social networking media (WeChat), v) willing to be followed up (Months 3 and 6), vi) should own a smart phone or a similar device.

Study instruments: Structured questionnaires.

Interventions: The 2-month intervention includes i) interactive online support groups and ii) immediate preventive 'SOS' cue to action messages to be sent to fellow support group members in need via WeChat. Besides, basic health education messages will be sent to both the intervention and the control groups.

Main outcome measures: self-reported 7-day point prevalence (pp) quit rate of smokers at 6 months post end-of-intervention.

Data analysis and expected results: Baseline characteristics between the two groups will be compared using t-test and chi-square test as appropriate. To evaluate efficacy in terms of the primary outcome, absolute risk reduction (ARR), relative risk reduction (RRR) and number needed to treat (NNT) at Months 3 and 6 and their 95% confidence intervals will be derived. Mixed effects models will be used to compare the differential changes on the outcome variables across the time points Months 0, 3 and 6 between the two study arms with adjustment for potential confounding variables. Significance differences in smoking cessation will be found among the two groups.

03

Conditions studied

  • Self Efficacy
  • Health Behavior

Browse trials for

Keywords

  • randomized controlled trial
  • smoking cessation
  • social support
  • positive effect
  • online social networking
  • theory-based
04

In context

Smoking Cessation Reclassified

1,582 studies on the registry are indexed under Smoking Cessation; 198 are open to participants now.

This study's planned enrollment of 408 is above the median of 164 across 1,424 interventional studies indexed under Smoking Cessation.

Browse Smoking Cessation studies →

Lead sponsor

Chinese University of Hong Kong is the lead sponsor of 1,454 studies on the registry; 474 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Compared within Smoking Cessation, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Health Behavior. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Current smokers who have smoked at least one cigarette in the past seven days prior to the baseline survey
  • Age 18 years old or above
  • Able to communicate in Chinese (Cantonese)
  • Having access to a smart phone or mobile electronic devices and social networking media (WeChat), v) willing to be followed up (Months 3 and 6)
  • Should own a smart phone or a similar device

Exclusion criteria

Exclusion Criteria:

  • Physically or mentally unfit
  • Having participated in smoking cessation programs (last six months)
06

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
408 participants (estimated)

Study arms

  • Experimental
    WeChat interactive peer support group

    Participants will be grouped together by the researcher to form closed online peer support groups (with group names they choose). Activities on the WeChat groups serve two functions: i) It enhances social support among peer members toward smoking cessation. ii) The online support group also enhances the participants' positive affect.

    Behavioral: Basic health education messages · Behavioral: WeChat interactive peer support group

  • Active comparator
    Basic health education messages

    Members of the control group will receive health education messages that will also be sent to the intervention group through WeChat. The messages include topics on physical and psychological aspects of perceived severity of smoking and perceived benefits of smoking cessation, and tips/skills on resisting situational temptations that may lead to relapse.

    Behavioral: Basic health education messages

Interventions

  • BehavioralBasic health education messages

    Messages containing basic health education materials, including perceived severity of smoking, perceived benefit of smoking cessation and tips on resisting situational temptations will be sent to the participants of both arms through WeChat after randomization takes place.

  • BehavioralWeChat interactive peer support group

    Participants will be grouped together by the researcher to form closed online peer support groups (with group names they choose). Activities on the WeChat groups serve two functions: i) It enhances social support among peer members toward smoking cessation. ii) The online support group also enhances the participants' positive affect.

07

What researchers measure

Primary outcomes

  1. Self-reported 7-day point prevalence (pp) quit rate

    Self-reported 7-day point prevalence (pp) quit rate of smokers at 6 months post end-of-intervention

    Time frame: 6 months

Secondary outcomes

  1. Number of cigarettes consumed per day as compared to that of the baseline

    Number of cigarettes consumed per day as compared to that of the baseline at 6 months post end-of-intervention

    Time frame: 6 months

  2. Positive and Negative Affect Scale score

    Positive and Negative Affect Scale score as compared to that of the baseline at 6 months post end-of-intervention. Positive and Negative Affect Scale is consisted of two subscales, i.e. Positive Affect Scale (total score is ranged from 10 to 50, the higher value represents a better outcome) and Negative Affect Scale (total score is ranged from 10 to 50, the higher value represents a worse outcome). Two subscales will not be combined to compute a total score.

    Time frame: 6 months

  3. Smoking Self-Efficacy Questionnaire score

    Smoking Self-Efficacy Questionnaire score as compared to that of the baseline at 6 months post end-of-intervention. The total score is ranged from 12 to 60. The higher values represents a better outcome.

    Time frame: 6 months

  4. Subjective Norms Scale score

    Subjective Norms Scale score as compared to that of the baseline at 6 months post end-of-intervention. The total score is 6 to 30. The higher value represents a better outcome.

    Time frame: 6 months

  5. Attitude Towards Smoking Scale score

    Attitude Towards Smoking Scale score as compared to that of the baseline at 6 months post end-of-intervention. The total score is ranged from 8 to 56. The higher values represents a better outcome.

    Time frame: 6 months

08

Study locations

1 site
  • Centre for Health Behaviours Research, the Chinese University of Hong Kong
    Hong Kong, 666888, Hong Kong
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2015 to primary completion in Jul 2017, 23 months.

Of 547 non-industry interventional studies with no phase under Smoking Cessation, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 23 months is close to that.

Counting every sponsor, half of 564 studies reached it within 24 months; a quarter within 12 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 18, 2017
First posted
Jan 2, 2018
StartActual
Aug 1, 2015
Primary completionActual
Jul 31, 2017
CompletionEst.
Jan 31, 2018
Last update
Jan 2, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 2, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03387800
Responsible party
Zixin Wang (Research Assistant Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Jan 2, 2018
Start date
Aug 1, 2015
Primary completion
Jul 31, 2017
Completion
Jan 31, 2018 (estimated)
Last update
Jan 2, 2018

Study contacts

Zixin Wang, PhD
principal investigator · Chinese University of Hong Kong

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion